Key result
Smoking combined with type 2 diabetes is linked to selectively lower HDL in Afro-Caribbean adults.
Why the study?
Whether cigarette smoking exerts differential effects on serum lipids in the presence of type 2 diabetes in an Afro-Caribbean population with a low prevalence of heart disease was uncertain.
Does cigarette smoking exert differential effects on serum lipids in the presence of type 2 diabetes in an Afro-Caribbean population residing in the U.S. Virgin Islands?
Observational
Does cigarette smoking exert differential effects on serum lipids in the presence of type 2 diabetes in an Afro-Caribbean population residing in the U.S. Virgin Islands?
While smoking and type 2 diabetes independently have no significant effect on HDL cholesterol in this Afro-Caribbean population, their combination produces a selective HDL-lowering effect, highlighting the need for targeted smoking-cessation interventions in diabetic smokers.
Answers are grounded in this paper and cite their sources.
May support hypothesis of differential smoking-lipid effects in diabetes; leaves open need for prospective confirmation in Afro-Caribbean groups.
This study investigates whether cigarette smoking exerts differential effects on serum lipids in the presence of type 2 diabetes in an Afro-Caribbean population with a low prevalence of heart disease residing in the U.S. Virgin Islands (USVI). Using population‑based data from the Virgin Islands Diabetes Study, lipid profiles were compared by smoking and diabetes status to determine how metabolic and genetic protections characteristic of Afro-Caribbean populations influence vulnerability to dyslipidemia. The analyses revealed that, independently, smoking and diabetes have no significant effect on HDL cholesterol (HDL), although expected effects were observed for other lipid fractions. However, this resistance to change in HDL collapses when diabetes and cigarette smoking occur together, producing a selective HDL‑lowering effect found only in diabetic smokers. This investigation sheds light on the longstanding paradox of high diabetes prevalence and low heart disease mortality in the USVI and underscores the importance of targeted smoking‑cessation interventions for the small subgroup of diabetic smokers.
No takes yet. Share an insight, caveat, or question.
Eugene S. Tull (2026) conducted an observational in Type 2 diabetes and dyslipidemia. Cigarette smoking and type 2 diabetes vs. Non-smokers and/or non-diabetics was evaluated on Serum lipid profiles, specifically HDL cholesterol. Cigarette smoking and type 2 diabetes together produced a selective HDL-lowering effect in Afro-Caribbean adults, whereas neither had a significant effect on HDL independently.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: